Testing a hydrogel for treating anal fistulas
Part of Digestive system clinical trials.
This trial tests a hydrogel made from natural materials to help heal a specific type of anal fistula. It may be an option if you have a single high transsphincteric fistula with a seton in place for at least four weeks.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have one anal fistula that goes through both sphincter muscles, with one internal opening and one or two external openings, and a seton (a thin flexible tube) has been in place for at least four weeks.
- You do not have Crohn's disease, ulcerative colitis, or another autoimmune condition that is not stable.
- You are not pregnant, and if you could become pregnant, you are not currently pregnant.
- You are not taking antiplatelet drugs (like clopidogrel) unless they can be stopped 5–7 days before surgery.
- You are not allergic to products from pigs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a device called BioHealx for closing anal fistulas that have not healed after previous treatment. It aims to see how well the device works in real-world use.
This trial tests a new collagen paste against standard flap surgery for a type of anal fistula. If you've already had a draining seton placed, you may be able to join this study to see which treatment works better.
This trial tests whether a special tissue therapy can help heal complex anal fistulas that involve a large part of the sphincter muscle. It is for adults who need surgery for this condition and do not have certain other health issues.
This Phase 1 study tests whether a donated-cell treatment (given with a minor procedure) can help heal simple anal fistulas. It mainly focuses on safety first, but may also look at how well the fistula closes.
This trial compares two surgical techniques to treat a complex type of anal fistula (an abnormal tunnel between the anal canal and skin). It aims to find which approach offers better healing and fewer risks.
This trial tests a new cell-based treatment (E-CEL UVEC cells) injected directly into perianal fistulas—abnormal tunnels near the anus that can cause pain and drainage. The goal is to help these fistulas heal without surgery.
Hear when a new Fistula in Ano trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.